We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer (GAST-TaxXel)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00669370
Recruitment Status : Unknown
Verified April 2008 by University of Turku.
Recruitment status was:  Recruiting
First Posted : April 30, 2008
Last Update Posted : April 30, 2008
Information provided by:
University of Turku

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2009
  Study Completion Date : No date given